PSCH Invesco S&P SmallCap Health Care ETF

ETF 57.29 Delayed

ETF quote, holdings, sector allocation, technicals, and options analytics. Expected move IV rank history Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

PSCH $57.29 —
Key stats
$57.29
52-Week Range
$39.08 – $58.15
YTD
+30.64%
IV Rank (30D)
10.27
Straddle Price
$3.40
P/C Vol Ratio
0.24
Open
$56.42
Day Range
$56.23 – $57.16
Volume
7,215
Prev Close
$55.75
About

Invesco S&P SmallCap Health Care ETF (PSCH) ETF

No description available.

Exchange
XNAS
Inception
2010-04-07
Has Options
Yes
Homepage
https://www.invesco.com/us/etfs
Fund profile
holdings as of Nov 5, 2026issuer datathrough Aug 2026flows, SEC filings
Sector Health Care#17 of 29 by assets Invesco US Index-tracking
Expense ratio
0.29%
prospectus, filed Dec 18, 2025
Assets
$180M
shares × price, Nov 6, 2026
Trailing yield
0.00%
paid quarterly
Average daily volume
$1.3M
30 sessions
Holdings
71
top 10 are 35.2%
Listed
Apr 7, 2010
Nasdaq
Closure risk, 12 months
0.9%
low · model
Tracking difference
-0.19 pts
vs index, after fees, FY 2025
FrenzyCap ETF score
58
how it is built
Cost70
Liquidity37
Scale46
Diversification74

Moves with. US large-cap stocks (36% of its variance, beta 0.94); Small caps over large (20% of its variance, beta 0.74); Long Treasuries (4% of its variance, beta 0.22). These factors explain 57% of its daily moves over the last year.

Stated objective. The Invesco S&P SmallCap Health Care ETF (the Fund) seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600 Capped Health Care Index (the Underlying Index). (from the fund's prospectus)

All 71 holdingsFlow historySimilar fundsOverlap toolAll Health Care ETFs

Fund flows
through Aug 2026SEC filings
Aug 2026
+$15M
latest reported month
Latest 3 months
+$25M
+13.4% of assets
Latest 12 months
+$1.4M
+0.8% of assets
Sep 2025: −$2.1MOct 2025: −$3.3MOctNov 2025: +$1.9MDec 2025: −$1.8MDecJan 2026: −$1.8MFeb 2026: −$3.5MFebMar 2026: −$11M−$11MApr 2026: −$2.9MAprMay 2026: +$894KJun 2026: +$6.0MJunJul 2026: +$3.2MAug 2026: +$15M+$15MAug
View as a table
Net flows of PSCH by month, Sep 2025 to Aug 2026
MonthNet flow
Aug 2026+$15M
Jul 2026+$3.2M
Jun 2026+$6.0M
May 2026+$894K
Apr 2026−$2.9M
Mar 2026−$11M
Feb 2026−$3.5M
Jan 2026−$1.8M
Dec 2025−$1.8M
Nov 2025+$1.9M
Oct 2025−$3.3M
Sep 2025−$2.1M

Net creations and redemptions from the fund's SEC filings, which become public about 60 days after each quarter. Every month since 84 months ago

Similar funds
FundOverlapFeeAssets1Y
RZGInvesco S&P SmallCap 600 Pure Growth ETF23%0.35%$114M+11.1%compare
XHSState Street SPDR S&P Health Care Services ETF21%0.35%$243M+37.9%compare
XSMOInvesco S&P SmallCap Momentum ETF20%0.35%$2.7B+6.1%compare
XHEState Street SPDR S&P Health Care Equipment ETF19%0.35%$158M+16.8%compare
XPHState Street SPDR S&P Pharmaceuticals ETF18%0.35%$466M+33.1%compare

Ranked by how much of the two portfolios is the same securities.

Look-through: what the holdings say
weights as of Nov 5, 2026issuer data
Holdings vs fair value
+13.8%
49% under, 28% over · 100% covered
Price / earnings
—
33% loss-making · 100% covered
Price / book · sales
2.8 · 2.0
revenue growth +9.6%
Above 200-day average
76%
66% above 50-day · by weight
Short interest
11.8%
of float, weighted · 7.7 days to cover
Insider buying
5%
of weight had net insider buying, 90 days; 44% net selling
13F holders
+3.8%
change in shares held by institutions, latest quarter
Reporting earnings
10.1%
of weight in 7 days; 10.1% in 14
Implied correlation
0.40
fund IV 33.9% vs holdings 52.9% · board
Largest contributors below fair value
SUPN+50%ALKS+30%RDNT+39%OGN+50%ACHC+50%
Largest contributors above fair value
TGTX−24%TFX−20%VCEL−40%PTGX−12%LGND−15%
Holdings reporting in the next 14 days · weighted implied move this week 1.33%
TGTX11/09 · 4.5% · ±13.0%RDNT11/09 · 3.0% · ±13.4%LQDA11/10 · 1.8% · ±11.8%AZTA11/10 · 0.8% · ±16.5%

Each figure is the fund's holdings weighted by position size, using our data on those stocks, and covers only the share of the stock holdings stated. Positive fair value means the holdings trade below our estimate.

What changed in the portfolio
Nov 3, 2026 → Nov 4, 2026
ActionHoldingWeight beforeWeight afterShares vs flows
ExitGKOSGlaukos Corp7.20%——
IncreaseSUPNSupernus Inc1.29%3.53%+257.0%
ExitINDVIndivior Pharmaceuticals Inc2.19%——

0 new, 0 exited, 0 increased and 0 decreased between the fund's two latest holdings reports; turnover 2.6%. Full holdings and history

Under the hood
fiscal year to Aug 31, 2025SEC census
Authorized participants
7 active
of 41 with agreements; top 3 did 79%
Created · redeemed
$8.3M · $47M
over the fiscal year
Redemptions in kind
100%
creations 100% in kind
Creation unit
10,000
shares
Securities lending
31.09%
of assets on loan on average; earned 3.9 bp
Return vs index
-0.19 pts
after fees; +0.11 before; daily s.d. 0.17

From the fund's annual census filing with the SEC. In-kind redemptions are what let an ETF shed appreciated securities without realising gains.

ETF Profile
holdings as of 2026-11-05
Holdings
72
AUM
$180.3M
Provider
Invesco
Inception
2010-04-07
Exchange
XNAS
Data As Of
2026-11-05
Expense Ratio
0.29%
Dividend Yield
0.00%
Distribution
Quarterly
Recent distributions
Ex-Date Pay Date Amount Type
2026-03-23 2026-03-27 $0.0003 CD
2025-09-22 2025-09-26 $0.0026 CD
2025-06-23 2025-06-27 $0.0020 CD
2025-03-24 2025-03-28 $0.0142 CD
2024-12-23 2024-12-27 $0.0180 CD
2024-06-24 2024-06-28 $0.0659 CD
Asset Allocation
Top Holdings
top 50 of 72 holdings
Symbol Name Weight % Asset Class Country
PTGX Protagonist Therapeutics Inc 4.77% Equity (US) US
TGTX TG Therapeutics Inc 4.48% Equity (US) US
ALKS Alkermes PLC 4.07% Equity (Foreign) IE
TFX Teleflex Inc 3.51% Equity (US) US
SUPN Supernus Inc 3.51% Equity (US) US
LGND Ligand Pharmaceuticals Inc 3.25% Equity (US) US
RDNT RadNet Inc 3.01% Equity (US) US
PTCT PTC Therapeutics Inc 2.98% Equity (US) US
MMSI Merit Medical Systems Inc 2.91% Equity (US) US
CON Concentra Group Holdings Parent Inc 2.72% Equity (US) US
ITGR Integer Holdings Corp 2.35% Equity (US) US
ICUI ICU Medical Inc 2.28% Equity (US) US
LFST LifeStance Health Group Inc 1.97% Equity (US) US
OGN Organon & Co 1.97% Equity (US) US
AMRX Amneal Pharmaceuticals Inc 1.96% Equity (US) US
WAY Waystar Holding Corp 1.90% Equity (US) US
LQDA Liquidia Corp 1.80% Equity (US) US
ACHC Acadia Healthcare Co Inc 1.76% Equity (US) US
ATRC AtriCure Inc 1.70% Equity (US) US
ARQT Arcutis Biotherapeutics Inc 1.68% Equity (US) US
PRVA Privia Health Group Inc 1.67% Equity (US) US
ADMA ADMA Biologics Inc 1.61% Equity (US) US
ACAD ACADIA Pharmaceuticals Inc 1.49% Equity (US) US
VCEL Vericel Corp 1.44% Equity (US) US
CRVL CorVel Corp 1.44% Equity (US) US
PGNY Progyny Inc 1.44% Equity (US) US
NHC National HealthCare Corp 1.43% Equity (US) US
NEOG Neogen Corp 1.39% Equity (US) US
MD Pediatrix Medical Group Inc 1.38% Equity (US) US
TMDX TransMedics Group Inc 1.30% Equity (US) US
XNCR Xencor Inc 1.27% Equity (US) US
ADUS Addus HomeCare Corp 1.26% Equity (US) US
UFPT UFP Technologies Inc 1.25% Equity (US) US
PRGO Perrigo Co PLC 1.19% Equity (US) US
NEO NeoGenomics Inc 1.15% Equity (US) US
PBH Prestige Consumer Healthcare Inc 1.14% Equity (US) US
FTRE Fortrea Holdings Inc 1.06% Equity (US) US
VCYT Veracyte Inc 1.05% Equity (US) US
INSP Inspire Medical Systems Inc 1.05% Equity (US) US
SRPT Sarepta Therapeutics Inc 1.01% Equity (US) US
RCUS Arcus Biosciences Inc 1.01% Equity (US) US
AMN AMN Healthcare Services Inc 1.00% Equity (US) US
LMAT LeMaitre Vascular Inc 0.97% Equity (US) US
OMCL Omnicell Inc 0.94% Equity (US) US
ENOV Enovis Corp 0.90% Equity (US) US
SDGR Schrodinger Inc/United States 0.89% Equity (US) US
ASTH Astrana Health Inc 0.89% Equity (US) US
HRMY Harmony Biosciences Holdings Inc 0.88% Equity (US) US
CNMD CONMED Corp 0.86% Equity (US) US
AZTA Azenta Inc 0.80% Equity (US) US
Non-Equity Breakdown
Invesco S&P SmallCap Health Care ETF · NPORT-P period 2026-08-31 (filed 2026-10-30)
Net assets: $184M · 74 total positions · equity 99.97% · non-equity 30.28%
Non-equity holdings — 3 positions, 30.28% of NAV
Category Weight Value Positions
Short-term investment 30.28% $55.7M 3
Chart
Seasonality
'21'22'23'24'25'26Avg
Jan5.92%-13.40%6.42%-3.86%6.94%0.81%0.47%
Feb0.18%1.91%-4.23%1.56%-5.95%-3.01%-1.59%
Mar-1.46%1.35%-3.70%2.01%0.91%-5.17%-1.01%
Apr0.95%-13.12%0.77%-5.44%-2.32%8.15%-1.83%
May-1.68%-4.02%-4.17%3.93%-0.76%0.44%-1.04%
Jun3.91%-0.45%2.58%-1.64%-0.12%16.81%3.52%
Jul-2.69%7.18%0.64%9.67%-4.66%0.86%1.83%
Aug0.49%-6.38%-6.16%2.71%8.76%1.63%0.17%
Sep-5.15%-6.27%-9.45%0.52%0.53%-4.56%-4.06%
Oct-0.68%2.57%-4.26%-4.26%0.73%8.60%0.45%
Nov-6.84%1.72%4.48%8.83%7.98%3.31%*3.25%
Dec6.23%-6.38%11.95%-7.90%-2.36%--0.31%
Total-1.69%-31.79%-6.90%4.61%8.79%29.13%0.36%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $54.53
SMA 50: $53.63
SMA 200: $48.63
Current: $57.16
EMA 12: $55.63
EMA 26: $54.66
MACD: 0.9714 | Signal: 0.2363
BULLISH
ADX (14): 21.39
WEAK TREND
+DI: 36.40
−DI: 21.25

Momentum Oscillators

RSI (14): 62.35
NEUTRAL
Stoch %K: 64.63
Stoch %D: 71.35
Williams %R: -21.04

Volume & Volatility

BB Upper: $57.94
BB Lower: $51.11
NEUTRAL
OBV: 458,140
Vol SMA 20: 28,683
Vol ROC: -56.60%
ATR: $1.12
True Range: $1.41
HV 20: 29.8%
HV 30: 27.3%
HV 60: 21.6%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
All PSCH news →
Showing 1–10 of 50
Page 1 of 5

PSCH Options Activity & IV Rank

PSCH IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 26.5%
7-DTE IV: 33.3%
Expected Move: $3.40
7-DTE Move: $2.62
Days to Exp: 39 (2026-12-18)

Options Flow · All expiries

Call Volume: 46
Put Volume: 11
P/C Volume: 0.239
BULLISH
Call OI: 85
Put OI: 7
P/C OI: 0.082
Total OI: 92

ATM Options Pricing

ATM Call: $1.75
ATM Put: $1.65
Call %: 3.1%
Put %: 2.9%

Chain Summary

Chain Volume: 57
Chain OI: 92
Last Updated: 11/9/2026
Spread Scanner
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
No data
30 DTE / 10d —
— pts EXTREME
No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)0.7LowNov 9
IV Rank (30 DTE)10.3LowNov 9
Straddle Price (30 DTE)$3.40Nov 9
Beta Analysis

Risk Metrics

Beta: 0.8619
Alpha: 22.32%
Correlation: 0.5788
R-Squared: 33.5%
Stock Volatility: 20.5%
Market Volatility: 13.8%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Beta & Alpha Over Time

PSCH Institutional Ownership (13F)

Filings for 2026-06-30 · 30 already for 2026-09-30
Diluted shares outstanding: 454,200,000 (as of 2026-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

73 filers784,253 shares$38.80M value0.17% of float
# Filer Shares Value % of Total % of Float Period
1 Bank of America Corp Custodian 81,354 $4.26M 10.98% 0.02% 2026-06-30
2 HARBOR CAPITAL ADVISORS, INC. 66,725 $3.47M 8.95% 0.01% 2026-09-30
3 LPL Financial LLC Custodian 61,117 $3.18M 8.20% 0.01% 2026-09-30
4 IHT Wealth Management, LLC 60,120 $3.15M 8.11% 0.01% 2026-06-30
5 Morgan Stanley Custodian 49,245 $2.58M 6.65% 0.01% 2026-06-30
6 Wells Fargo & Company Custodian 48,607 $2.55M 6.56% 0.01% 2026-06-30
7 Royal Bank of Canada Custodian 25,746 $1.35M 3.47% <0.01% 2026-06-30
8 PARR MCKNIGHT WEALTH MANAGEMENT GROUP, LLC 25,759 $1.34M 3.46% <0.01% 2026-09-30
9 Beacon Pointe Advisors, LLC 24,626 $1.29M 3.32% <0.01% 2026-06-30
10 Raymond James Financial, Inc. Custodian 21,800 $1.14M 2.94% <0.01% 2026-06-30
11 UBS Group AG Custodian 20,891 $1.09M 2.82% <0.01% 2026-06-30
12 Montecito Bank & Trust 20,543 $1.07M 2.76% <0.01% 2026-09-30
13 McGuire Investment Group, LLC 13,576 $706.90K 1.82% <0.01% 2026-09-30
14 Ameriprise Financial, Inc. Custodian 13,089 $685.42K 1.77% <0.01% 2026-06-30
15 Pacific Sun Financial Corp 13,070 $684.43K 1.76% <0.01% 2026-06-30
16 Envestnet Asset Management, Inc. 12,440 $651.42K 1.68% <0.01% 2026-06-30
17 Jaffetilchin Investment Partners, LLC 11,480 $601.17K 1.55% <0.01% 2026-06-30
18 WBI INVESTMENTS, LLC 11,327 $589.79K 1.52% <0.01% 2026-09-30
19 Gladstone Institutional Advisory LLC 9,862 $516.44K 1.33% <0.01% 2026-06-30
20 Cordoba Advisory Partners LLC 9,514 $497.01K 1.28% <0.01% 2026-09-30
21 Cascade Financial Partners, LLC 9,441 $494.39K 1.27% <0.01% 2026-06-30
22 Cetera Investment Advisers Custodian 8,908 $466.46K 1.20% <0.01% 2026-06-30
23 Cambridge Investment Research Advisors, Inc. 8,175 $426.00K 1.10% <0.01% 2026-09-30
24 OSAIC HOLDINGS, INC. Custodian 7,956 $416.71K 1.07% <0.01% 2026-06-30
25 Baird Financial Group, Inc. 7,593 $397.62K 1.02% <0.01% 2026-06-30
1 filers$223.90K notional
# Filer Notional Value % of Total Period
1 Belvedere Trading LLC $223.90K 100.00% 2026-09-30
# Filer Notional Value % of Total Period
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
14.28K
SI % of Float
0.44%
Days to Cover
1.26
Short Vol Ratio
70.8%
Free Float
—
Float %
—
Short interest 2026-10-15 • Short volume 2026-11-06
PSCH Constituent Performance

Click any bar to view the full quote for that stock.

PSCH Constituents (67 of 67)
Symbol Name Weight % Price 1 Day 1 Week 1 Month
PTGX Protagonist Therapeutics Inc 4.77% $135.69 +2.76%-2.64%-6.34%
TGTX TG Therapeutics Inc 4.48% $61.08 +2.10%+1.88%+10.51%
ALKS Alkermes PLC 4.07% $46.51 +1.32%+3.60%+15.52%
TFX Teleflex Inc 3.51% $155.25 +2.90%+10.36%+23.51%
SUPN Supernus Inc 3.51% $27.64 +5.68%-34.05%-35.21%
LGND Ligand Pharmaceuticals Inc 3.25% $314.52 +2.72%+2.44%+1.09%
RDNT RadNet Inc 3.01% $79.84 +5.05%+9.22%+11.68%
PTCT PTC Therapeutics Inc 2.98% $65.2 -0.37%+7.10%+3.62%
MMSI Merit Medical Systems Inc 2.91% $89.21 +2.27%+5.81%-0.60%
CON Concentra Group Holdings Parent Inc 2.72% $42.7 +1.13%+5.86%+13.73%
ITGR Integer Holdings Corp 2.35% $126.64 +0.06%+0.07%+0.09%
ICUI ICU Medical Inc 2.28% $180.24 +4.72%+11.00%+9.96%
LFST LifeStance Health Group Inc 1.97% $14.88 +8.10%+12.25%+19.27%
OGN Organon &amp; Co 1.97% $13.87 -0.04%+0.33%+0.69%
AMRX Amneal Pharmaceuticals Inc 1.96% $21.27 +5.61%+4.06%+6.19%
WAY Waystar Holding Corp 1.90% $29.06 +2.50%+3.27%+9.04%
LQDA Liquidia Corp 1.80% $48 +8.11%+14.70%+73.47%
ACHC Acadia Healthcare Co Inc 1.76% $38.58 +4.27%+30.25%+28.26%
ATRC AtriCure Inc 1.70% $57.9 -1.09%-3.31%+1.08%
ARQT Arcutis Biotherapeutics Inc 1.68% $25.44 -0.43%-18.62%-2.97%
PRVA Privia Health Group Inc 1.67% $24.61 +0.78%+15.65%+14.73%
ADMA ADMA Biologics Inc 1.61% $12.95 +1.73%+17.09%+27.21%
ACAD ACADIA Pharmaceuticals Inc 1.49% $18.86 -11.19%-7.89%-2.86%
VCEL Vericel Corp 1.44% $58.74 +7.54%+45.00%+44.61%
CRVL CorVel Corp 1.44% $82.47 -0.83%-0.91%+5.84%
PGNY Progyny Inc 1.44% $35.65 +2.32%+21.22%+27.19%
NHC National HealthCare Corp 1.43% $211.26 +1.15%+4.54%-8.10%
NEOG Neogen Corp 1.39% $12.16 +3.44%+2.92%+1.37%
MD Pediatrix Medical Group Inc 1.38% $31.41 +0.37%+2.26%+16.66%
TMDX TransMedics Group Inc 1.30% $94.58 +7.18%+41.86%+20.99%
XNCR Xencor Inc 1.27% $39.5 +10.49%+33.18%+57.75%
ADUS Addus HomeCare Corp 1.26% $123.15 -0.93%-2.07%+6.65%
UFPT UFP Technologies Inc 1.25% $324.81 +7.03%+14.38%+9.80%
PRGO Perrigo Co PLC 1.19% $16.69 +5.30%+5.97%+8.03%
NEO NeoGenomics Inc 1.15% $17.45 +3.59%+5.79%+7.69%
PBH Prestige Consumer Healthcare Inc 1.14% $43.34 +0.85%-12.84%-11.54%
FTRE Fortrea Holdings Inc 1.06% $22.83 +3.96%+14.04%+8.71%
VCYT Veracyte Inc 1.05% $25.97 +7.49%-47.00%-41.00%
INSP Inspire Medical Systems Inc 1.05% $63.6 -0.59%-5.37%-11.04%
SRPT Sarepta Therapeutics Inc 1.01% $17.77 -0.25%-2.97%+1.92%
RCUS Arcus Biosciences Inc 1.01% $18.85 +3.12%+5.60%-22.56%
AMN AMN Healthcare Services Inc 1.00% $37.81 +4.48%-17.39%+4.22%
LMAT LeMaitre Vascular Inc 0.97% $81.72 +1.03%+0.57%-1.44%
OMCL Omnicell Inc 0.94% $38.12 +2.09%+4.70%+3.39%
ENOV Enovis Corp 0.90% $28.14 +3.63%+36.49%+54.22%
SDGR Schrodinger Inc/United States 0.89% $33.5 +12.34%+27.91%+29.29%
ASTH Astrana Health Inc 0.89% $33.57 -2.70%-8.98%-12.58%
HRMY Harmony Biosciences Holdings Inc 0.88% $33.77 +1.99%-10.92%-11.67%
CNMD CONMED Corp 0.86% $52.12 +1.20%+11.87%+14.90%
AZTA Azenta Inc 0.80% $40.9 +4.44%+15.05%+8.29%